APA način citiranja (7. izdanje)

Locquet, M., Beaudart, C., Pétermans, J., Reginster, J., & Bruyère, O. (2019). EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences.

Čikaški stil citiranja (17. izdanje)

Locquet, Médéa, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, i Olivier Bruyère. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.

MLA način citiranja (9. izdanje)

Locquet, Médéa, et al. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. 2019.